Back to Search
CHARLES HICKS, DMD
DMD
General Practice Dentistry
NPI: 1902053598Individual
Specialties, Licenses & Credentials
General Practice DentistryPrimary
Dentist — General Practice
Code: 1223G0001X
DN0013368(FL)
Clinical Trials (1)
1
Linked Trials
0
Recruiting
0
With Results
Research & Publications (20)
Improvement in lipoatrophy associated with highly active antiretroviral therapy in human immunodeficiency virus-infected patients switched from stavudine to abacavir or zidovudine: the results of the TARHEEL study.
PMID 14699460·Clin Infect Dis·2004
3-trial
The NEAT study: a 48-week open-label study to compare the antiviral efficacy and safety of GW433908 versus nelfinavir in antiretroviral therapy-naive HIV-1-infected patients.
PMID 14707788·J Acquir Immune Defic Syndr·2004
3-trial
Preliminary guidelines for the evaluation and management of dyslipidemia in adults infected with human immunodeficiency virus and receiving antiretroviral therapy: Recommendations of the Adult AIDS Clinical Trial Group Cardiovascular Disease Focus Group.
PMID 11073755·Clin Infect Dis·2000
6-review
Amprenavir: a new human immunodeficiency virus type 1 protease inhibitor.
PMID 10868554·Clin Ther·2000
6-review
Effects of protease inhibitors on hyperglycemia, hyperlipidemia, and lipodystrophy: a 5-year cohort study.
PMID 10888979·Arch Intern Med·2000
8-other
Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel.
PMID 10647802·JAMA·2000
6-review
Amprenavir: a review of its clinical potential in patients with HIV infection.
PMID 11152018·Drugs·2000
6-review
Facial asymmetry involving the parotid gland of an infant.
PMID 19498212·Clin Pediatr (Phila)·2010
5-case
HIV-1 envelope induces memory B cell responses that correlate with plasma antibody levels after envelope gp120 protein vaccination or HIV-1 infection.
PMID 19625640·J Immunol·2009
4-observational
Comparison of once-daily fosamprenavir boosted with either 100 or 200 mg of ritonavir, in combination with abacavir/lamivudine: 96-week results from COL100758.
PMID 19320570·AIDS Res Hum Retroviruses·2009
4-observational
Top stories of 2008. Beyond abacavir/3TC: good news on first-line regimens.
PMID 19219957·AIDS Clin Care·2009
8-other
Report from the 16th Conference on Retroviruses and Opportunistic Infections. Investigational pharmacologic boosters.
PMID 19548333·J Watch AIDS Clin Care·2009
8-other
Heterogeneous neutralizing antibody and antibody-dependent cell cytotoxicity responses in HIV-1 elite controllers.
PMID 19414990·AIDS·2009
4-observational
Report from the 16th Conference on Retroviruses and Opportunistic Infections. Timing of ART initiation--still no definitive answers.
PMID 19544614·J Watch AIDS Clin Care·2009
8-other
Predictors of loss of virologic response in subjects who simplified to lopinavir/ritonavir monotherapy from lopinavir/ritonavir plus zidovudine/lamivudine.
PMID 19292590·AIDS Res Hum Retroviruses·2009
4-observational
Polyclonal B cell differentiation and loss of gastrointestinal tract germinal centers in the earliest stages of HIV-1 infection.
PMID 19582166·PLoS Med·2009
8-other
In vivo gp41 antibodies targeting the 2F5 monoclonal antibody epitope mediate human immunodeficiency virus type 1 neutralization breadth.
PMID 19193787·J Virol·2009
8-other
Designing sexual health services for young people: a methodology for capturing the user voice.
PMID 19187423·Health Soc Care Community·2009
8-other
Lipid changes associated with antiretroviral therapy: results differ by reporting approach.
PMID 19534666·Curr HIV Res·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 800 ZEAGLER DR, SUITE 330
PALATKA, FL 32177 - Phone
- (386) 325-6000
Quick Facts
- NPI
- 1902053598
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Clinical Trials
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile